Corcept Therapeutics, Inc. (CORT)
87.89
+0.57
(+0.65%)
USD |
NASDAQ |
Jun 29, 14:45
Corcept Therapeutics Cash from Investing (TTM) : 77.47M for March 31, 2026
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 77.47M |
| December 31, 2025 | 69.76M |
| September 30, 2025 | 17.24M |
| June 30, 2025 | -41.44M |
| March 31, 2025 | -171.76M |
| December 31, 2024 | -177.60M |
| September 30, 2024 | -96.15M |
| June 30, 2024 | -161.68M |
| March 31, 2024 | -125.58M |
| December 31, 2023 | 90.91M |
| September 30, 2023 | 56.57M |
| June 30, 2023 | 161.35M |
| March 31, 2023 | 143.64M |
| December 31, 2022 | -114.33M |
| September 30, 2022 | 43.38M |
| June 30, 2022 | 22.37M |
| March 31, 2022 | 88.91M |
| December 31, 2021 | 136.13M |
| September 30, 2021 | 6.875M |
| June 30, 2021 | -31.60M |
| March 31, 2021 | -142.28M |
| December 31, 2020 | -119.26M |
| September 30, 2020 | -192.47M |
| June 30, 2020 | -182.52M |
| March 31, 2020 | -97.73M |
| Date | Value |
|---|---|
| December 31, 2019 | -117.83M |
| September 30, 2019 | -57.60M |
| June 30, 2019 | -36.79M |
| March 31, 2019 | -56.84M |
| December 31, 2018 | -90.77M |
| September 30, 2018 | -116.46M |
| June 30, 2018 | -94.60M |
| March 31, 2018 | -88.34M |
| December 31, 2017 | -73.46M |
| September 30, 2017 | -46.08M |
| June 30, 2017 | -34.53M |
| March 31, 2017 | -19.58M |
| December 31, 2016 | -0.194M |
| September 30, 2016 | -0.102M |
| June 30, 2016 | -0.012M |
| March 31, 2016 | -0.005M |
| December 31, 2015 | -0.017M |
| September 30, 2015 | -0.034M |
| June 30, 2015 | -0.05M |
| March 31, 2015 | -0.098M |
| December 31, 2014 | -0.174M |
| September 30, 2014 | -0.214M |
| June 30, 2014 | -0.263M |
| March 31, 2014 | -0.219M |
| December 31, 2013 | -0.127M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Abeona Therapeutics, Inc. | 105.78M |
| QT Imaging Holdings, Inc. | -0.141M |
| Liquidia Corp. | -8.836M |
| Indivior Pharmaceuticals, Inc. | -80.60M |
| Forum Markets, Inc. | -55.82M |